8-KOther EventsExhibits & Filings

CVS HEALTH Corp 8-K Report, Corporate Update (Oct 14, 2015)

Filed October 14, 2015For Securities:CVS

Summary

This Form 8-K filing by CVS Health Corporation (CVS) on October 14, 2015, details the early results of its private exchange offers and consent solicitations related to the recently acquired Omnicare, Inc. notes. The company successfully tendered a significant majority of Omnicare's outstanding senior notes for its own newly issued senior notes, with over 96% of the 2022 notes and 98% of the 2024 notes exchanged by the early tender date. This move is a crucial step in integrating Omnicare's debt structure into CVS Health's, simplifying its capital structure and likely reducing borrowing costs. The high participation rate indicates strong investor confidence in CVS Health's creditworthiness and its strategic integration of Omnicare. The company also obtained the necessary consents to amend the terms of the remaining Omnicare notes, eliminating restrictive covenants, which further streamlines its financial obligations.

Key Highlights

  • 1CVS Health completed a successful private exchange offer for Omnicare's senior notes, with high participation rates from eligible holders.
  • 2Approximately 96.2% of the $400 million in outstanding 4.75% Senior Notes due 2022 issued by Omnicare were tendered.
  • 3Approximately 98.2% of the $300 million in outstanding 5.00% Senior Notes due 2024 issued by Omnicare were tendered.
  • 4The exchange offered new CVS Health notes (4.75% Senior Notes due 2022 and 5.00% Senior Notes due 2024) in exchange for the Omnicare notes.
  • 5CVS Health also successfully solicited consents to amend the terms of the Existing Omnicare Notes, eliminating substantially all restrictive covenants and certain events of default.
  • 6The approval of proposed amendments for each series of Omnicare notes was obtained, with consent from holders of a majority of the aggregate principal amount outstanding.
  • 7A Registration Rights Agreement was entered into to govern the exchange or registration of the new CVS Health notes.

Frequently Asked Questions

The primary purpose was to report the early results of CVS Health's private exchange offers and consent solicitations for the senior notes of Omnicare, Inc., which CVS Health had recently acquired. This action aimed to integrate Omnicare's debt into CVS Health's capital structure.

The exchange offers were highly successful. By the early tender date, over 96% of Omnicare's 2022 senior notes and over 98% of its 2024 senior notes were tendered for exchange into new CVS Health notes.

The successful consent solicitation means that CVS Health has received approval from noteholders to amend the indentures governing the Omnicare notes. These amendments will eliminate most restrictive covenants and certain default provisions, simplifying the debt obligations associated with the acquired company.

This filing primarily relates to debt management and integration following an acquisition. While it doesn't detail immediate financial results, the successful exchange and amendment of debt suggest a more streamlined and potentially less restrictive debt profile for CVS Health going forward, which is generally positive for financial flexibility.